Antiproliferative activity of the Michael adducts of aroylacrylic acids and cyclic amines
Antiproliferative activity of twenty one Michael adducts of aroylacrylic acids and cyclic amines ( N -Me-piperazine, imidazole, 2-Me-imidazole, and indole) was tested toward five human tumor cell lines (HeLa, LS174, K562, FemX, MDA-MB-361) in vitro. Compounds exerted antiproliferative activity in th...
Saved in:
Published in: | Molecular diversity Vol. 18; no. 3; pp. 577 - 592 |
---|---|
Main Authors: | , , , |
Format: | Journal Article |
Language: | English |
Published: |
Cham
Springer International Publishing
01-08-2014
Springer Nature B.V |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | Antiproliferative activity of twenty one Michael adducts of aroylacrylic acids and cyclic amines (
N
-Me-piperazine, imidazole, 2-Me-imidazole, and indole) was tested toward five human tumor cell lines (HeLa, LS174, K562, FemX, MDA-MB-361) in vitro. Compounds exerted antiproliferative activity in the high to the single-digit micromolar concentrations, causing increase of the cell population fraction in S phase and apoptosis.
N
-Me-piperazine and imidazole derivatives of aroylacrylic acids substituted with bulky alkyl substituents (2,4-di-
i
-Pr-Ph-, 2,4,6-tri-Et-Ph-, or
β
-tetrahydronaphthyl-) showed the best potency, while indole adducts were proved as the inferior antiproliferative agents. Few compounds showed significant selectivity, tumor versus healthy cells, with selectivity index
∼
60
for the most selective congener. An unbiased in silico distinction between more and less potent compounds was obtained from 3D QSAR models derived by alignment-independent GRIND-2 descriptors.
Graphical Abstract |
---|---|
AbstractList | (ProQuest: ... denotes formulae and/or non-USASCII text omitted; see image) Antiproliferative activity of twenty one Michael adducts of aroylacrylic acids and cyclic amines (...-Me-piperazine, imidazole, 2-Me-imidazole, and indole) was tested toward five human tumor cell lines (HeLa, LS174, K562, FemX, MDA-MB-361) in vitro. Compounds exerted antiproliferative activity in the high to the single-digit micromolar concentrations, causing increase of the cell population fraction in S phase and apoptosis. ...-Me-piperazine and imidazole derivatives of aroylacrylic acids substituted with bulky alkyl substituents (2,4-di-...-Pr-Ph-, 2,4,6-tri-Et-Ph-, or ...-tetrahydronaphthyl-) showed the best potency, while indole adducts were proved as the inferior antiproliferative agents. Few compounds showed significant selectivity, tumor versus healthy cells, with selectivity index ... for the most selective congener. An unbiased in silico distinction between more and less potent compounds was obtained from 3D QSAR models derived by alignment-independent GRIND-2 descriptors. [Figure not available: see fulltext.][PUBLICATION ABSTRACT] Antiproliferative activity of twenty one Michael adducts of aroylacrylic acids and cyclic amines ( N -Me-piperazine, imidazole, 2-Me-imidazole, and indole) was tested toward five human tumor cell lines (HeLa, LS174, K562, FemX, MDA-MB-361) in vitro. Compounds exerted antiproliferative activity in the high to the single-digit micromolar concentrations, causing increase of the cell population fraction in S phase and apoptosis. N -Me-piperazine and imidazole derivatives of aroylacrylic acids substituted with bulky alkyl substituents (2,4-di- i -Pr-Ph-, 2,4,6-tri-Et-Ph-, or β -tetrahydronaphthyl-) showed the best potency, while indole adducts were proved as the inferior antiproliferative agents. Few compounds showed significant selectivity, tumor versus healthy cells, with selectivity index ∼ 60 for the most selective congener. An unbiased in silico distinction between more and less potent compounds was obtained from 3D QSAR models derived by alignment-independent GRIND-2 descriptors. Graphical Abstract Antiproliferative activity of twenty one Michael adducts of aroylacrylic acids and cyclic amines (N-Me-piperazine, imidazole, 2-Me-imidazole, and indole) was tested toward five human tumor cell lines (HeLa, LS174, K562, FemX, MDA-MB-361) in vitro. Compounds exerted antiproliferative activity in the high to the single-digit micromolar concentrations, causing increase of the cell population fraction in S phase and apoptosis. N-Me-piperazine and imidazole derivatives of aroylacrylic acids substituted with bulky alkyl substituents (2,4-di-i-Pr-Ph-, 2,4,6-tri-Et-Ph-, or β-tetrahydronaphthyl-) showed the best potency, while indole adducts were proved as the inferior antiproliferative agents. Few compounds showed significant selectivity, tumor versus healthy cells, with selectivity index ~60 for the most selective congener. An unbiased in silico distinction between more and less potent compounds was obtained from 3D QSAR models derived by alignment-independent GRIND-2 descriptors. |
Author | Tošić, Ana V. Juranić, Ivan O. Kolundžija, Branka Drakulić, Branko J. |
Author_xml | – sequence: 1 givenname: Ivan surname: Juranic middlename: O fullname: Juranic, Ivan O – sequence: 2 givenname: Ana surname: Tosic middlename: V fullname: Tosic, Ana V – sequence: 3 givenname: Branka surname: Kolundzija fullname: Kolundzija, Branka – sequence: 4 givenname: Branko surname: Drakulic middlename: J fullname: Drakulic, Branko J |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/24874228$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kEtP3TAQhS1Exav8gG6qSN2wSZnxI48lQi0ggdgUia4sxx73GuUm1E6Q8u_x5V6qqlJXMxp_54znHLP9YRyIsU8IXxGgPk-IIKAElGWreFPKPXaEqhalAnzcz71osMS2xUN2nNITQFahOGCHXDa15Lw5Yj8vhik8x7EPnqKZwgsVxuYSpqUYfTGtqLgLdmWoL4xzs53SZmziuPTGxqUPNvPBpcIMrrCLfRusw0DpI_vgTZ_odFdP2MP3bz8ur8vb-6uby4vb0kpQU6lIcGFcXasKgLipXN1hV_uOk6tImQqoEZXl0jvsKlE5cj4ryIMB8q0SJ-xs65uv-D1TmvQ6JEt9bwYa56RRSRR100qe0S__oE_jHIf8uw0FLReqwkzhlrJxTCmS188xrE1cNILe5K63ueucu97krmXWfN45z92a3B_Fe9AZ4Fsg5afhF8W_Vv_X9RX8bI-o |
CitedBy_id | crossref_primary_10_31857_S0132344X23600182 crossref_primary_10_1134_S1070328423600584 crossref_primary_10_3389_fmicb_2017_01767 crossref_primary_10_1002_jhet_2375 |
Cites_doi | 10.1007/BF00119860 10.1093/nar/gkr1132 10.1021/ja01190a041 10.1021/ci300314k 10.1002/(SICI)1096-987X(199905)20:7<730::AID-JCC8>3.0.CO;2-T 10.3390/12010025 10.1021/jm00145a002 10.1021/ci800037t 10.1016/0022-1759(83)90303-4 10.1021/ml200141e 10.1021/cb200404c 10.1021/jm0502889 10.1016/j.ejmech.2013.01.006 10.1016/j.ejmech.2011.04.043 10.1016/0022-1759(91)90327-C 10.1023/B:JCAM.0000035186.90683.f2 10.1021/ja01598a058 10.1021/ci100031x |
ContentType | Journal Article |
Copyright | Springer International Publishing Switzerland 2014 |
Copyright_xml | – notice: Springer International Publishing Switzerland 2014 |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 3V. 7X7 7XB 88E 88I 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. M0S M1P M2P PQEST PQQKQ PQUKI PRINS Q9U 7X8 |
DOI | 10.1007/s11030-014-9528-4 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Science Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central ProQuest Central Essentials AUTh Library subscriptions: ProQuest Central ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) Science Database ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef ProQuest Science Journals (Alumni Edition) ProQuest Central Student ProQuest Central Basic ProQuest Central Essentials ProQuest Science Journals ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete Health Research Premium Collection ProQuest Medical Library ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest One Academic ProQuest Medical Library (Alumni) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | ProQuest Science Journals (Alumni Edition) MEDLINE |
Database_xml | – sequence: 1 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology Physics |
EISSN | 1573-501X |
EndPage | 592 |
ExternalDocumentID | 3351411701 10_1007_s11030_014_9528_4 24874228 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- -4W -58 -5G -BR -EM -Y2 -~C .86 .VR 06C 06D 0R~ 0VY 123 1SB 2.D 203 28- 29M 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2P1 2VQ 2~H 30V 3SX 3V. 4.4 406 408 409 40E 53G 5QI 5VS 67Z 6NX 7X7 88E 88I 8FE 8FH 8FI 8FJ 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AABYN AAFGU AAHNG AAIAL AAJKR AANXM AANZL AAPBV AARHV AARTL AATNV AATVU AAUYE AAWCG AAYFA AAYIU AAYQN AAYTO ABBBX ABBXA ABDZT ABECU ABELW ABFGW ABFTV ABHLI ABHQN ABJNI ABJOX ABKAS ABKCH ABKTR ABMNI ABMQK ABNWP ABPLI ABQBU ABSXP ABTEG ABTHY ABTKH ABTMW ABULA ABUWG ABWNU ABXPI ACBMV ACBRV ACBXY ACBYP ACGFS ACGOD ACHSB ACHXU ACIGE ACIPQ ACKNC ACMDZ ACMLO ACOKC ACOMO ACSNA ACTTH ACVWB ACWMK ADBBV ADHHG ADHIR ADIMF ADINQ ADKNI ADKPE ADMDM ADOAH ADOXG ADRFC ADTPH ADURQ ADYFF ADYPR ADZKW AEBTG AEEQQ AEFIE AEFTE AEGAL AEGNC AEJHL AEJRE AEKMD AENEX AEOHA AEPYU AESKC AESTI AETLH AEVLU AEVTX AEXYK AFEXP AFGCZ AFKRA AFLOW AFNRJ AFQWF AFWTZ AFZKB AGAYW AGDGC AGGBP AGGDS AGJBK AGMZJ AGQMX AGWIL AGWZB AGYKE AHAVH AHBYD AHMBA AHSBF AHYZX AIAKS AIIXL AILAN AIMYW AITGF AJBLW AJDOV AJRNO AJZVZ AKMHD AKQUC ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AMYQR AOCGG AOSHJ ARMRJ ASPBG AVWKF AXYYD AZFZN AZQEC B-. BA0 BBWZM BDATZ BENPR BGNMA BPHCQ BVXVI CAG CCPQU COF CS3 CSCUP DDRTE DL5 DNIVK DPUIP DU5 DWQXO EBD EBLON EBS EIOEI EJD EMOBN EPAXT ESBYG F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNUQQ GNWQR GQ6 GQ7 GQ8 GXS HCIFZ HF~ HG5 HG6 HMCUK HMJXF HQYDN HRMNR HVGLF HZ~ I09 IHE IJ- IKXTQ IWAJR IXC IXD IXE IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JZLTJ KDC KOV KOW LAK LK5 LLZTM M1P M2P M4Y M7R MA- N2Q NB0 NDZJH NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OAM OVD P19 P9N PF0 PQQKQ PROAC PSQYO PT4 PT5 Q2X QOK QOR QOS R4E R89 R9I RHV RIG RNI RNS ROL RPX RRX RSV RZC RZE RZK S16 S1Z S26 S27 S28 S3B SAP SBY SCLPG SCM SDH SDM SHX SISQX SJYHP SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZN T13 T16 TEORI TSG TSK TSV TUC TUS U2A U9L UG4 UKHRP UNUBA UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WJK WK6 WK8 YLTOR Z45 Z7U Z7V Z87 Z8O Z8P Z91 ZMTXR ZOVNA ~A9 ~EX ~KM AACDK AAEOY AAJBT AAQLM AASML AAYZH ABAKF ACAOD ACDTI ACZOJ AEFQL AEMSY AFBBN AGQEE AGRTI AIGIU ALIPV CGR CUY CVF ECM EIF H13 NPM AAYXX CITATION 7XB 8FK K9. PQEST PQUKI PRINS Q9U 7X8 |
ID | FETCH-LOGICAL-c405t-5e323ad775600e2a6d7b1b7fb2ed6e5a60e836c24fd1b636dedf323ef0a0ef953 |
IEDL.DBID | AEJHL |
ISSN | 1381-1991 |
IngestDate | Fri Oct 25 04:52:14 EDT 2024 Thu Oct 10 18:00:46 EDT 2024 Thu Nov 21 21:43:50 EST 2024 Tue Oct 15 23:51:24 EDT 2024 Sat Dec 16 12:10:32 EST 2023 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | Michael adducts 3D QSAR Selectivity Antiproliferative activity Aroylacrylic acids |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c405t-5e323ad775600e2a6d7b1b7fb2ed6e5a60e836c24fd1b636dedf323ef0a0ef953 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 24874228 |
PQID | 1540923561 |
PQPubID | 54625 |
PageCount | 16 |
ParticipantIDs | proquest_miscellaneous_1541378942 proquest_journals_1540923561 crossref_primary_10_1007_s11030_014_9528_4 pubmed_primary_24874228 springer_journals_10_1007_s11030_014_9528_4 |
PublicationCentury | 2000 |
PublicationDate | 2014-08-01 |
PublicationDateYYYYMMDD | 2014-08-01 |
PublicationDate_xml | – month: 08 year: 2014 text: 2014-08-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Cham |
PublicationPlace_xml | – name: Cham – name: Netherlands – name: Dordrecht |
PublicationTitle | Molecular diversity |
PublicationTitleAbbrev | Mol Divers |
PublicationTitleAlternate | Mol Divers |
PublicationYear | 2014 |
Publisher | Springer International Publishing Springer Nature B.V |
Publisher_xml | – name: Springer International Publishing – name: Springer Nature B.V |
References | Drakulić, Juranić, Stanojković, Juranić (CR10) 2005; 48 Papa, Schwenk, Villani, Klingsberg (CR12) 1948; 70 Abubshait (CR13) 2007; 12 Hawkins, Nicholls (CR23) 2012; 52 Goodford (CR15) 1985; 28 Gieldanowski, Steuden (CR8) 1981; 29 CR17 CR16 Li, Liu, Zhang, Knudson, Li, Lai, Simmerling, Slayden, Tonge (CR3) 2011; 2 Wang, Xiao, Suzek, Zhang, Wang, Zhou, Han, Karapetyan, Dracheva, Shoemaker, Bolton, Gindulyte, Bryant (CR6) 2012; 40 Couquelet, Couquelet, Cluzel, Tronche (CR7) 1969; 4 Durán, Comesaña, Pastor (CR18) 2008; 48 Halgren (CR25) 1999; 20 Gaillard, Carrupt, Testa, Boudon (CR26) 1994; 8 Pedretti, Villa, Vistoli (CR27) 2004; 18 Hayashi, Neve, Hirose, Kuboki, Shimada, Kepinski, Nozaki (CR4) 2012; 7 Tamam, Soliman, El-Gendy, Al-Kady (CR14) 1987; 9 Clothier (CR21) 1995; 43 Drakulić, Stanojković, Žižak, Dabović (CR9) 2011; 46 Ohno, Abe (CR20) 1991; 145 CR2 CR5 CR24 CR22 Mosmann (CR19) 1983; 6 Bougault (CR1) 1908; 15 Vitorović-Todorović, Erić-Nikolić, Kolundžija, Hamel, Ristić, Juranić, Drakulić (CR11) 2013; 62 15368917 - J Comput Aided Mol Des. 2004 Mar;18(3):167-73 7550637 - Methods Mol Biol. 1995;43:109-18 7305635 - Arch Immunol Ther Exp (Warsz). 1981;29(2):257-65 23353745 - Eur J Med Chem. 2013 Apr;62:40-50 7914913 - J Comput Aided Mol Des. 1994 Apr;8(2):83-96 6606682 - J Immunol Methods. 1983 Dec 16;65(1-2):55-63 18693718 - J Chem Inf Model. 2008 Sep;48(9):1813-23 22140110 - Nucleic Acids Res. 2012 Jan;40(Database issue):D400-12 21570747 - Eur J Med Chem. 2011 Aug;46(8):3265-73 16107160 - J Med Chem. 2005 Aug 25;48(17):5600-3 22267981 - ACS Med Chem Lett. 2011 Nov 10;2(11):818-823 1765652 - J Immunol Methods. 1991 Dec 15;145(1-2):199-203 20235588 - J Chem Inf Model. 2010 Apr 26;50(4):572-84 22234040 - ACS Chem Biol. 2012 Mar 16;7(3):590-8 3892003 - J Med Chem. 1985 Jul;28(7):849-57 18891860 - J Am Chem Soc. 1948 Oct;70(10):3356-60 23082786 - J Chem Inf Model. 2012 Nov 26;52(11):2919-36 17693951 - Molecules. 2007 Jan 10;12(1):25-42 J Couquelet (9528_CR7) 1969; 4 MD Vitorović-Todorović (9528_CR11) 2013; 62 T Mosmann (9528_CR19) 1983; 6 GH Tamam (9528_CR14) 1987; 9 SA Abubshait (9528_CR13) 2007; 12 Y Wang (9528_CR6) 2012; 40 A Durán (9528_CR18) 2008; 48 X Li (9528_CR3) 2011; 2 M Ohno (9528_CR20) 1991; 145 A Pedretti (9528_CR27) 2004; 18 D Papa (9528_CR12) 1948; 70 9528_CR22 9528_CR24 PCD Hawkins (9528_CR23) 2012; 52 K Hayashi (9528_CR4) 2012; 7 P Gaillard (9528_CR26) 1994; 8 RH Clothier (9528_CR21) 1995; 43 9528_CR2 PJ Goodford (9528_CR15) 1985; 28 9528_CR5 TA Halgren (9528_CR25) 1999; 20 BJ Drakulić (9528_CR9) 2011; 46 9528_CR16 9528_CR17 J Gieldanowski (9528_CR8) 1981; 29 J Bougault (9528_CR1) 1908; 15 BJ Drakulić (9528_CR10) 2005; 48 |
References_xml | – ident: CR22 – volume: 8 start-page: 83 year: 1994 end-page: 96 ident: CR26 article-title: Molecular lipophilicity potential, a tool in 3D QSAR: method and applications publication-title: J Comput Aided Mol Des doi: 10.1007/BF00119860 contributor: fullname: Boudon – volume: 40 start-page: D400 year: 2012 end-page: D412 ident: CR6 article-title: PubChem’s BioAssay database publication-title: Nucleic Acids Res doi: 10.1093/nar/gkr1132 contributor: fullname: Bryant – ident: CR2 – ident: CR16 – volume: 70 start-page: 3356 year: 1948 end-page: 3360 ident: CR12 article-title: -Aroylacrylic acids publication-title: J Am Chem Soc doi: 10.1021/ja01190a041 contributor: fullname: Klingsberg – volume: 52 start-page: 2919 year: 2012 end-page: 2936 ident: CR23 article-title: Conformer generation with OMEGA: learning from the data set and the analysis of failures publication-title: J Chem Inf Model doi: 10.1021/ci300314k contributor: fullname: Nicholls – volume: 20 start-page: 730 year: 1999 end-page: 748 ident: CR25 article-title: MMFF VII. Characterization of MMFF94, MMFF94s and other widely available force fields for conformational energies and for intermolecular interaction energies and geometries publication-title: J Comput Chem doi: 10.1002/(SICI)1096-987X(199905)20:7<730::AID-JCC8>3.0.CO;2-T contributor: fullname: Halgren – volume: 15 start-page: 491 year: 1908 end-page: 515 ident: CR1 article-title: Sur l‘acide benzoylacrylique publication-title: Ann Chim Phys contributor: fullname: Bougault – volume: 9 start-page: 1 year: 1987 end-page: 10 ident: CR14 article-title: Alkylation of indole with -aroylacrylic acids and some studies on the alkylated products publication-title: J Chem Soc Pak contributor: fullname: Al-Kady – volume: 12 start-page: 25 year: 2007 end-page: 42 ident: CR13 article-title: An efficient synthesis and reactions of novel indolylpyridazinone derivatives with expected biological activity publication-title: Molecules doi: 10.3390/12010025 contributor: fullname: Abubshait – volume: 43 start-page: 109 year: 1995 end-page: 118 ident: CR21 article-title: The FRAME cytotoxicity test publication-title: Methods Mol Biol contributor: fullname: Clothier – volume: 28 start-page: 849 year: 1985 end-page: 857 ident: CR15 article-title: A computational procedure for determining energetically favorable binding sites on biologically important macromolecules publication-title: J Med Chem doi: 10.1021/jm00145a002 contributor: fullname: Goodford – volume: 29 start-page: 257 year: 1981 end-page: 265 ident: CR8 article-title: Screening system for the evaluation of preparations with potential cytostatic and immunotropic activity. II. Derivatives of propionic and hydroxybutyric acids and of tetrahydrofuran-2-one publication-title: Arch Immunol Ther Exp contributor: fullname: Steuden – volume: 48 start-page: 1813 year: 2008 end-page: 1823 ident: CR18 article-title: Development and validation of AMANDA, a new algorithm for selecting highly relevant regions in molecular interaction fields publication-title: J Chem Inf Model doi: 10.1021/ci800037t contributor: fullname: Pastor – volume: 4 start-page: 127 year: 1969 end-page: 130 ident: CR7 article-title: Antibacterial -amino- -aroylpropionic acids publication-title: Chim Ther contributor: fullname: Tronche – volume: 6 start-page: 55 year: 1983 end-page: 63 ident: CR19 article-title: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays publication-title: J Immunol Methods doi: 10.1016/0022-1759(83)90303-4 contributor: fullname: Mosmann – ident: CR17 – volume: 2 start-page: 818 year: 2011 end-page: 823 ident: CR3 article-title: CoA adducts of 4-oxo-4-phenylbut-2-enoates: inhibitors of MenB from the menaquinone biosynthesis pathway publication-title: ACS Med Chem Lett doi: 10.1021/ml200141e contributor: fullname: Tonge – volume: 7 start-page: 590 year: 2012 end-page: 598 ident: CR4 article-title: Rational design of an auxin antagonist of the SCF auxin receptor complex publication-title: ACS Chem Biol doi: 10.1021/cb200404c contributor: fullname: Nozaki – volume: 48 start-page: 5600 year: 2005 end-page: 5603 ident: CR10 article-title: 2-[(Carboxymethyl) sulfanyl]-4-oxo-4-arylbutanoic acids selectively suppressed proliferation of neoplastic human HeLa cells. A SAR/QSAR study publication-title: J Med Chem doi: 10.1021/jm0502889 contributor: fullname: Juranić – ident: CR5 – volume: 62 start-page: 40 year: 2013 end-page: 50 ident: CR11 article-title: ( -4-Aryl-4-oxo-2-butenoic acid amides, chalcone-aroylacrylic acid chimeras: design, antiproliferative activity and inhibition of tubulin polymerization publication-title: Eur J Med Chem doi: 10.1016/j.ejmech.2013.01.006 contributor: fullname: Drakulić – volume: 46 start-page: 3265 year: 2011 end-page: 3273 ident: CR9 article-title: Antiproliferative activity of aroylacrylic acids. Structure–activity study based on molecular interaction fields publication-title: Eur J Med Chem doi: 10.1016/j.ejmech.2011.04.043 contributor: fullname: Dabović – volume: 145 start-page: 199 year: 1991 end-page: 203 ident: CR20 article-title: Rapid colorimetric assay for the quantification of leukemia inhibitory factor (LIF) and interleukin-6 (IL-6) publication-title: J Immunol Methods doi: 10.1016/0022-1759(91)90327-C contributor: fullname: Abe – ident: CR24 – volume: 18 start-page: 167 year: 2004 end-page: 173 ident: CR27 article-title: Vega—an open platform to develop chemo-bio-informatics applications, using plug-in architecture and script programming publication-title: J Comput Aided Mol Des doi: 10.1023/B:JCAM.0000035186.90683.f2 contributor: fullname: Vistoli – volume: 7 start-page: 590 year: 2012 ident: 9528_CR4 publication-title: ACS Chem Biol doi: 10.1021/cb200404c contributor: fullname: K Hayashi – volume: 2 start-page: 818 year: 2011 ident: 9528_CR3 publication-title: ACS Med Chem Lett doi: 10.1021/ml200141e contributor: fullname: X Li – volume: 48 start-page: 1813 year: 2008 ident: 9528_CR18 publication-title: J Chem Inf Model doi: 10.1021/ci800037t contributor: fullname: A Durán – volume: 8 start-page: 83 year: 1994 ident: 9528_CR26 publication-title: J Comput Aided Mol Des doi: 10.1007/BF00119860 contributor: fullname: P Gaillard – ident: 9528_CR16 – volume: 48 start-page: 5600 year: 2005 ident: 9528_CR10 publication-title: J Med Chem doi: 10.1021/jm0502889 contributor: fullname: BJ Drakulić – volume: 43 start-page: 109 year: 1995 ident: 9528_CR21 publication-title: Methods Mol Biol contributor: fullname: RH Clothier – volume: 12 start-page: 25 year: 2007 ident: 9528_CR13 publication-title: Molecules doi: 10.3390/12010025 contributor: fullname: SA Abubshait – volume: 62 start-page: 40 year: 2013 ident: 9528_CR11 publication-title: Eur J Med Chem doi: 10.1016/j.ejmech.2013.01.006 contributor: fullname: MD Vitorović-Todorović – ident: 9528_CR2 doi: 10.1021/ja01598a058 – volume: 70 start-page: 3356 year: 1948 ident: 9528_CR12 publication-title: J Am Chem Soc doi: 10.1021/ja01190a041 contributor: fullname: D Papa – volume: 52 start-page: 2919 year: 2012 ident: 9528_CR23 publication-title: J Chem Inf Model doi: 10.1021/ci300314k contributor: fullname: PCD Hawkins – volume: 145 start-page: 199 year: 1991 ident: 9528_CR20 publication-title: J Immunol Methods doi: 10.1016/0022-1759(91)90327-C contributor: fullname: M Ohno – ident: 9528_CR24 – volume: 40 start-page: D400 year: 2012 ident: 9528_CR6 publication-title: Nucleic Acids Res doi: 10.1093/nar/gkr1132 contributor: fullname: Y Wang – volume: 9 start-page: 1 year: 1987 ident: 9528_CR14 publication-title: J Chem Soc Pak contributor: fullname: GH Tamam – ident: 9528_CR22 doi: 10.1021/ci100031x – volume: 29 start-page: 257 year: 1981 ident: 9528_CR8 publication-title: Arch Immunol Ther Exp contributor: fullname: J Gieldanowski – ident: 9528_CR17 – volume: 4 start-page: 127 year: 1969 ident: 9528_CR7 publication-title: Chim Ther contributor: fullname: J Couquelet – volume: 28 start-page: 849 year: 1985 ident: 9528_CR15 publication-title: J Med Chem doi: 10.1021/jm00145a002 contributor: fullname: PJ Goodford – ident: 9528_CR5 – volume: 6 start-page: 55 year: 1983 ident: 9528_CR19 publication-title: J Immunol Methods doi: 10.1016/0022-1759(83)90303-4 contributor: fullname: T Mosmann – volume: 15 start-page: 491 year: 1908 ident: 9528_CR1 publication-title: Ann Chim Phys contributor: fullname: J Bougault – volume: 18 start-page: 167 year: 2004 ident: 9528_CR27 publication-title: J Comput Aided Mol Des doi: 10.1023/B:JCAM.0000035186.90683.f2 contributor: fullname: A Pedretti – volume: 20 start-page: 730 year: 1999 ident: 9528_CR25 publication-title: J Comput Chem doi: 10.1002/(SICI)1096-987X(199905)20:7<730::AID-JCC8>3.0.CO;2-T contributor: fullname: TA Halgren – volume: 46 start-page: 3265 year: 2011 ident: 9528_CR9 publication-title: Eur J Med Chem doi: 10.1016/j.ejmech.2011.04.043 contributor: fullname: BJ Drakulić |
SSID | ssj0010013 |
Score | 2.069529 |
Snippet | Antiproliferative activity of twenty one Michael adducts of aroylacrylic acids and cyclic amines (
N
-Me-piperazine, imidazole, 2-Me-imidazole, and indole) was... Antiproliferative activity of twenty one Michael adducts of aroylacrylic acids and cyclic amines (N-Me-piperazine, imidazole, 2-Me-imidazole, and indole) was... (ProQuest: ... denotes formulae and/or non-USASCII text omitted; see image) Antiproliferative activity of twenty one Michael adducts of aroylacrylic acids and... |
SourceID | proquest crossref pubmed springer |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 577 |
SubjectTerms | Acids Acrylates - chemistry Acrylates - pharmacology Amines - chemistry Amines - pharmacology Antineoplastic Agents - chemistry Antineoplastic Agents - pharmacology Biochemistry Biomedical and Life Sciences Cell Line, Tumor Cell Proliferation - drug effects Chemical engineering Full-Length Paper Humans Life Sciences Models, Molecular Molecular chemistry Molecular Conformation Organic Chemistry Pharmacy Polymer Sciences |
Title | Antiproliferative activity of the Michael adducts of aroylacrylic acids and cyclic amines |
URI | https://link.springer.com/article/10.1007/s11030-014-9528-4 https://www.ncbi.nlm.nih.gov/pubmed/24874228 https://www.proquest.com/docview/1540923561 https://search.proquest.com/docview/1541378942 |
Volume | 18 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT8MwDLbYJiQuvB-FgYLECVTUx5p2x4ltmhDiAkjbqcrykCZGN63bYf8eu48NNDjAqVWaJpEdO19ixwa4iYxxpOtyO3CEsVHhcVtIIWxNCY-cSAsj6b5z7yV87kftDoXJ8VZHF8n7fWmRzBT1-q4bJcTCnW_DbgZ0IlSBGi49Ac7tWqvz2Hta2Q4I1WTbrMglNwq3tGX-1Mj31WgDYm6YR7NVp7v3n_Huw26BMVkrnxQHsKWTQ9jOs04u8S3z-pTpEQxayXw0pbw9RucRwBndc6B0EmxiGGJDVrjVM1RQCzlPqVjMJsuxkLPleCSx_kilTCSKyaXMCj7Ikf4Y3rqd14eeXeRasCVCtrkdaN_zhQpDQkDaE1yFQ3cYmqGnFdeB4I6OfC69hlHukPtcaWXwD20c4WjTDPwTqCaTRJ8B8yOuEObxUCvUECjivkCpV4RNBBm6LbgtaR5P85Aa8Tp4MlEtRqrFRLW4YUG95EpcSFcaI-xzEJgi9LPgevUZ5YKMHSLRk0VWx_XDqNnwLDjNubnqzcNdGoU-s-Cu5N2Xxn8byvmfal_AjkfMz3wF61Cdzxb6EiqpWlwVE5ae_cGg_QkrbuRx |
link.rule.ids | 315,782,786,27933,27934,41073,42142,48344,48347,48357,49649,49652,49662,52153 |
linkProvider | Springer Nature |
linkToHtml | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3JTsMwEB1BEYIL-xJWI3ECRUrixkmPFQUVsVwoUnuKXC9SpZKipj3075nJUkCFA9wix3GssWf8xrMBXMbWesr3hRt60roo8IQrlZSuoYJHXmykVRTv3H6Jnrtx65bS5PAqFib3dq9Mkrmk_gx2o4pYqPrW3UZIV0LLsELJzoMarDS7vV5rbjwgWJPrWbFPfhR-Zcz8aZDvx9ECxlywj-bHzt3mvya8BRslymTNYltsw5JJd2C1qDs5w6fc71Nlu9BrppPBO1XusabIAc4o0oEKSrCRZYgOWelYz1BETdUko2Y5Hs2GUo1nw4HC_gOdMZlqpmYqb3gjV_o9eL277dy03bLagqsQtE3c0PCASx1FhIFMIIWO-n4_sv3AaGFCKTwTc6GCutV-X3Chjbb4hbGe9IxthHwfaukoNYfAeCw0Aj0RGY0yApmcS-R7TehEkqnbgauK6Ml7kVQj-UyfTFRLkGoJUS2pO3BSLUtS8leWIPDzEJoi-HPgYv4aOYPMHTI1o2nex-dR3KgHDhwUyzn_W4B6GiU_c-C6Wrsvg_82laM_9T6HtXbn6TF5vH9-OIb1gDZC7jl4ArXJeGpOYTnT07Ny934AD7Hm8Q |
linkToPdf | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1ZS8NAEB48UHzxPuK5gk9KaM5N-iRFW-qBCCroU9juAQVNS5M-9N87k6Mq6oP4FjabzbIzO_vNzgVwEhvjSNfldugIY6PA47aQQtiaCh45sRZGUrxz9yG6e44v25Qm57yOhSm83WuTZBnTQFma0rwxVKbxEfhG1bFQDQ7sZkjXQ7MwH6Aig4w-32pfd2-nhgSCOIXOFbvkU-HWhs2fBvl6NH3Dm99spcUR1Fn59-RXYblCn6xVsssazOh0HRbKepQTfCr8QWW2AS-tNO8PqaKP0WVucEYREFRogg0MQ9TIKod7hqJrLPOMmsVoMHkVcjR57Uvs31cZE6liciKLhjdysd-Ep0778aJrV1UYbIlgLrdD7Xu-UFFE2Eh7gquo5_Yi0_O04joU3NGxz6UXGOX2uM-VVga_0MYRjjbN0N-CuXSQ6h1gfswVAkAeaYWyAze_L1AeKEItgkzgFpzWBEiGZbKN5COtMq1agquW0KolgQX7NYmSat9lCQJCByErgkILjqevcceQGUSkejAu-rh-FDcDz4LtkrTTv3mov1FSNAvOajp-Gvy3qez-qfcRLN5fdpLbq7ubPVjyiA8Kh8J9mMtHY30As5kaH1aM_A6xW-9y |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Antiproliferative+activity+of+the+Michael+adducts+of+aroylacrylic+acids+and+cyclic+amines&rft.jtitle=Molecular+diversity&rft.au=Jurani%C4%87%2C+Ivan+O.&rft.au=To%C5%A1i%C4%87%2C+Ana+V.&rft.au=Kolund%C5%BEija%2C+Branka&rft.au=Drakuli%C4%87%2C+Branko+J.&rft.date=2014-08-01&rft.pub=Springer+International+Publishing&rft.issn=1381-1991&rft.eissn=1573-501X&rft.volume=18&rft.issue=3&rft.spage=577&rft.epage=592&rft_id=info:doi/10.1007%2Fs11030-014-9528-4&rft.externalDocID=10_1007_s11030_014_9528_4 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1381-1991&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1381-1991&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1381-1991&client=summon |